cobas® liat SARS-CoV-2 v2
By Roche Diagnostics · Switzerland

Summary
cobas® liat SARS-CoV-2 v2 is a nucleic acid test from Roche Diagnostics, listed for SARS-CoV-2. Registration status and availability vary by market.
Classification
- Category
- Molecular Assays
- Subcategory
- Respiratory PCR Panels
- Product Type
- Assay Kit
- Technology
- Sample-to-Answer
Application
- Application Area
- Respiratory, Emerging Pathogens
- Target Pathogens
- SARS-CoV-2
Workflow
- Sample Types
- Np Swab
Regulatory Status
Reported from manufacturer sources and not independently verified.
Buyer Notes
Listing compiled from the manufacturer product page. Confirm registration status in the target market, sample type, and instrument compatibility before issuing an RFQ.
Related Test Guides
From the manufacturer
Quoted verbatim from the manufacturer’s published product page. IVDmap did not write or verify this text.
Additionally, this test is intended to be used with nasal and nasopharyngeal swab specimens collected from individuals without signs and symptoms of COVID-19 (i.e., asymptomatic).
The cobas liat SARS-CoV-2 v2 nucleic acid test is intended for use as an aid in the diagnosis of COVID-19 if used in conjunction with other clinical and epidemiological information and laboratory find
Review and references
Compiled from public manufacturer materials and regulatory sources. Not independently verified and not reviewed by a named clinician.
2026-10-04
2026-10-06
availability varies
